Page last updated: 2024-08-21

ethambutol and MODS

ethambutol has been researched along with MODS in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Eller, P; Hackl, G; Hermann, J; Reisinger, AC; Vagena, FR	1
Alonso, E; Batlle, M; Marcos, P; Martínez de Lagrán, I; Plana, A; Tomasa, T	1

Other Studies

2 other study(ies) available for ethambutol and MODS

Article	Year
Tuberculosis sepsis after tocilizumab treatment. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Multiple Organ Failure; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sepsis; Treatment Outcome; Tuberculosis	2020
Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome. Medicina intensiva, 2017, Volume: 41, Issue:3 Topics: Antitubercular Agents; Combined Modality Therapy; Drug Combinations; Drug Hypersensitivity Syndrome; Ethambutol; Glucocorticoids; Herpesvirus 6, Human; Humans; Isoniazid; Leukapheresis; Male; Multiple Organ Failure; Plasmapheresis; Pyrazinamide; Rifampin; Roseolovirus Infections; Tuberculosis, Pleural; Young Adult	2017

Article

Year

Tuberculosis sepsis after tocilizumab treatment.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:11

Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Multiple Organ Failure; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sepsis; Treatment Outcome; Tuberculosis

2020

Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.

Medicina intensiva, 2017, Volume: 41, Issue:3

Topics: Antitubercular Agents; Combined Modality Therapy; Drug Combinations; Drug Hypersensitivity Syndrome; Ethambutol; Glucocorticoids; Herpesvirus 6, Human; Humans; Isoniazid; Leukapheresis; Male; Multiple Organ Failure; Plasmapheresis; Pyrazinamide; Rifampin; Roseolovirus Infections; Tuberculosis, Pleural; Young Adult

2017